Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;36(10):2298-2314.e11.
doi: 10.1016/j.cmet.2024.07.017. Epub 2024 Aug 20.

Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females

Affiliations

Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females

Brendan Cordeiro et al. Cell Metab. .

Abstract

Obesity has been implicated in the rise of autoimmunity in women. We report that obesity induces a serum protein signature that is associated with T helper 1 (Th1), interleukin (IL)-17, and multiple sclerosis (MS) signaling pathways selectively in human females. Females, but not male mice, subjected to diet-induced overweightness/obesity (DIO) exhibited upregulated Th1/IL-17 inflammation in the central nervous system during experimental autoimmune encephalomyelitis, a model of MS. This was associated with worsened disability and a heightened expansion of myelin-specific Th1 cells in the peripheral lymphoid organs. Moreover, at steady state, DIO increased serum levels of interferon (IFN)-α and potentiated STAT1 expression and IFN-γ production by naive CD4+ T cells uniquely in female mice. This T cell phenotype was driven by increased adiposity and was prevented by the removal of ovaries or knockdown of the type I IFN receptor in T cells. Our findings offer a mechanistic explanation of how obesity enhances autoimmunity.

Keywords: T cells; T helper 1 differentiation; autoimmunity; experimental autoimmune encephalomyelitis; interferon-α; multiple sclerosis; obesity; sex differences.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.J.A. is currently an employee of Bristol Myers Squibb. R.C.A. is on the advisory board for Progentec Diagnostics Inc.

References

    1. Reich DS, Lucchinetti CF, and Calabresi PA (2018). Multiple Sclerosis. N. Engl. J. Med 378, 169–180. 10.1056/NEJMra1401483. - DOI - PMC - PubMed
    1. Dendrou CA, Fugger L, and Friese MA (2015). Immunopathology of multiple sclerosis. Nat. Rev. Immunol 15, 545–558. 10.1038/nri3871. - DOI - PubMed
    1. Rasouli J, Ciric B, Imitola J, Gonnella P, Hwang D, Mahajan K, Mari ER, Safavi F, Leist TP, Zhang GX, and Rostami A (2015). Expression of GM-CSF in T Cells is increased in multiple sclerosis and suppressed by IFN-beta therapy. J. Immunol 194, 5085–5093. 10.4049/jimmunol.1403243. - DOI - PMC - PubMed
    1. McGinley MP, Goldschmidt CH, and Rae-Grant AD (2021). Diagnosis and treatment of multiple sclerosis: A review. JAMA 325, 765–779. 10.1001/jama.2020.26858. - DOI - PubMed
    1. Rangachari M, and Kuchroo VK (2013). Using EAE to better understand principles of immune function and autoimmune pathology. J. Autoimmun 45, 31–39. S0896-8411(13)00082-6 [pii] 10.1016/j.jaut.2013.06.008. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources